FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3040765955> ?p ?o ?g. }

• W3040765955 endingPage "108178" @default.
• W3040765955 startingPage "108178" @default.
• W3040765955 abstract "Abstract Background Methamphetamine is a highly addictive and abused psychostimulant. Symptoms of methamphetamine withdrawal including drug craving and anxiety that can drive relapse. Currently, there is no FDA approved treatment for methamphetamine use disorder, highlighting the need for research examining the neural mechanisms underlying psychostimulant-induced behaviors. Research indicates that the 5-HT2A receptor antagonist M100907 attenuates several psychostimulant-induced behaviors, including conditioned place preference (CPP). However, these findings have not been extended to methamphetamine. The present study investigated the effects of M100907 on acquisition of methamphetamine-CPP and methamphetamine-induced anxiety-like behavior. Methods Adult male rats were tested across eight consecutive days. Prior to methamphetamine administration (0 or 1 mg/kg, i.p.), rats were pretreated with their assigned dose of M100907 (0, 0.0025 .025 or 0.25 mg/kg, i.p.) and were placed into their initially non-preferred chamber. After four methamphetamine conditioning sessions, the effects of M100907 on methamphetamine-induced CPP were assessed. Following CPP testing, rats were screened for anxiety-like behaviors in the elevated plus-maze. Results Pretreatment with M100907 attenuated methamphetamine-induced CPP without producing any observable rewarding or aversive effects in methamphetamine naive rats. Additionally, M100907 blocked methamphetamine-induced increases in anxiety-like behavior and attenuated some indices of anxiety in methamphetamine naive rats. Conclusions Results suggest that blocking 5-HT2A receptors with the selective antagonist M100907 attenuates the rewarding effects of methamphetamine and does not produce any rewarding or aversive effects alone. Further, M100907 pretreatment blocked the anxiety-inducing effects of methamphetamine. Collectively, these data suggest that the 5-HT2A receptor subtype represents a novel target for treating methamphetamine use disorder." @default.
• W3040765955 created "2020-07-16" @default.
• W3040765955 creator A5001054821 @default.
• W3040765955 creator A5037680504 @default.
• W3040765955 creator A5084580069 @default.
• W3040765955 date "2020-10-01" @default.
• W3040765955 modified "2023-09-24" @default.
• W3040765955 title "Antagonizing serotonin 2A (5-HT2A) receptors attenuates methamphetamine-induced reward and blocks methamphetamine-induced anxiety-like behaviors in adult male rats" @default.
• W3040765955 cites W1550537001 @default.
• W3040765955 cites W1552025788 @default.
• W3040765955 cites W1606859536 @default.
• W3040765955 cites W1746115056 @default.
• W3040765955 cites W1913760354 @default.
• W3040765955 cites W1934404972 @default.
• W3040765955 cites W1968753027 @default.
• W3040765955 cites W1969855549 @default.
• W3040765955 cites W1980035963 @default.
• W3040765955 cites W1980604666 @default.
• W3040765955 cites W1982408943 @default.
• W3040765955 cites W1983334283 @default.
• W3040765955 cites W1990508321 @default.
• W3040765955 cites W1996402667 @default.
• W3040765955 cites W2003686526 @default.
• W3040765955 cites W2004377186 @default.
• W3040765955 cites W2004664745 @default.
• W3040765955 cites W2006833690 @default.
• W3040765955 cites W2008373614 @default.
• W3040765955 cites W2013387700 @default.
• W3040765955 cites W2013940388 @default.
• W3040765955 cites W2034150217 @default.
• W3040765955 cites W2037417281 @default.
• W3040765955 cites W2041561931 @default.
• W3040765955 cites W2047422895 @default.
• W3040765955 cites W2060921542 @default.
• W3040765955 cites W2068311250 @default.
• W3040765955 cites W2075903380 @default.
• W3040765955 cites W2082534552 @default.
• W3040765955 cites W2082999191 @default.
• W3040765955 cites W2085073153 @default.
• W3040765955 cites W2089464278 @default.
• W3040765955 cites W2091715004 @default.
• W3040765955 cites W2092609164 @default.
• W3040765955 cites W2096980898 @default.
• W3040765955 cites W2098536790 @default.
• W3040765955 cites W2104516271 @default.
• W3040765955 cites W2106862702 @default.
• W3040765955 cites W2120563989 @default.
• W3040765955 cites W2122062108 @default.
• W3040765955 cites W2122297603 @default.
• W3040765955 cites W2130449080 @default.
• W3040765955 cites W2143752285 @default.
• W3040765955 cites W2156201904 @default.
• W3040765955 cites W2157103026 @default.
• W3040765955 cites W2160512845 @default.
• W3040765955 cites W2161441546 @default.
• W3040765955 cites W2161516646 @default.
• W3040765955 cites W2167284547 @default.
• W3040765955 cites W2221169673 @default.
• W3040765955 cites W2262634587 @default.
• W3040765955 cites W2346301012 @default.
• W3040765955 cites W239922313 @default.
• W3040765955 cites W2407486591 @default.
• W3040765955 cites W2410368721 @default.
• W3040765955 cites W2517777642 @default.
• W3040765955 cites W2556362435 @default.
• W3040765955 cites W2608088535 @default.
• W3040765955 cites W2766632734 @default.
• W3040765955 cites W2785413961 @default.
• W3040765955 cites W2792327341 @default.
• W3040765955 cites W2891087637 @default.
• W3040765955 cites W2901296188 @default.
• W3040765955 doi "https://doi.org/10.1016/j.drugalcdep.2020.108178" @default.
• W3040765955 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32739601" @default.
• W3040765955 hasPublicationYear "2020" @default.
• W3040765955 type Work @default.
• W3040765955 sameAs 3040765955 @default.
• W3040765955 citedByCount "3" @default.
• W3040765955 countsByYear W30407659552021 @default.
• W3040765955 countsByYear W30407659552022 @default.
• W3040765955 crossrefType "journal-article" @default.
• W3040765955 hasAuthorship W3040765955A5001054821 @default.
• W3040765955 hasAuthorship W3040765955A5037680504 @default.
• W3040765955 hasAuthorship W3040765955A5084580069 @default.
• W3040765955 hasConcept C118552586 @default.
• W3040765955 hasConcept C126322002 @default.
• W3040765955 hasConcept C15744967 @default.
• W3040765955 hasConcept C169760540 @default.
• W3040765955 hasConcept C170493617 @default.
• W3040765955 hasConcept C2775864247 @default.
• W3040765955 hasConcept C2780376393 @default.
• W3040765955 hasConcept C53910766 @default.
• W3040765955 hasConcept C558461103 @default.
• W3040765955 hasConcept C71924100 @default.
• W3040765955 hasConcept C98274493 @default.
• W3040765955 hasConceptScore W3040765955C118552586 @default.
• W3040765955 hasConceptScore W3040765955C126322002 @default.
• W3040765955 hasConceptScore W3040765955C15744967 @default.
• W3040765955 hasConceptScore W3040765955C169760540 @default.

• next